AI assistant
Sending…
IBEX Ltd — Director's Dealing 2025
Feb 19, 2025
32752_dirs_2025-02-18_ff745fe4-835c-4e7c-825f-847e46fe5322.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IBEX Ltd (IBEX)
CIK: 0001720420
Period of Report: 2025-02-14
Reporting Person: Casteel Julie K (Chief Sales/Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Common Shares | M | 10000 | $12.75 | Acquired | 41190 | Direct |
| 2025-02-14 | Common Shares | M | 6574 | $19 | Acquired | 47764 | Direct |
| 2025-02-14 | Common Shares | S | 10000 | $27.04 | Disposed | 37764 | Direct |
| 2025-02-14 | Common Shares | S | 6574 | $27.04 | Disposed | 31190 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | Stock Option (Right to Buy Common Shares) | $12.75 | M | 10000 | Disposed | 2030-06-30 | Common Shares (10000) | Direct |
| 2025-02-14 | Stock Option (Right to Buy Common Shares) | $19 | M | 6574 | Disposed | 2030-08-07 | Common Shares (6574) | Direct |
Footnotes
F1: The shares subject to this option are fully vested and exercisable.
More from IBEX Ltd
Regulatory Filings
2026
May 13
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27